Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? - PubMed (original) (raw)
. 2010 Mar-Apr;50(2):141-9.
[Article in English, Portuguese]
Affiliations
- PMID: 21125150
Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia?
[Article in English, Portuguese]
Josie Budag Matsuda et al. Rev Bras Reumatol. 2010 Mar-Apr.
Abstract
Introduction: Fibromyalgia is a rheumatic syndrome characterized by diffuse and chronic pain associated with fatigue, sleep disorders, anxiety, depression, memory loss, and dizziness. Although the physiological mechanisms that control fibromyalgia have not been precisely established, neuroendocrine, genetic or molecular factors may be involved in fibromyalgia.
Objective: The aim of the present study was to characterize serotonin receptor (5-HT2A) and catechol-O-methyltransferase (COMT) gene polymorphisms in Brazilian patients with fibromyalgia and to evaluate the participation of these polymorphisms in the etiology of the disease.
Material and methods: Genomic DNA extracted from 102 blood samples (51 patients, 51 controls) was used for molecular characterization of the 5-HT2A and COMT gene polymorphisms by PCR-RFLP.
Results: Analysis of the 5-HT2A polymorphism revealed a frequency of 25.49% C/C, 49.02% T/C and 25.49% T/T in patients, and of 17.65% C/C, 62.74% T/C and 19.61% T/T in the control group, with no differences between the two groups.Analysis of the COMT polymorphism in patients showed a frequency of 17.65% and 45.10% for genotypes H/H and L/H, respectively. In the control group the frequency was 29.42% for H/H and 60.78% for L/H, also with no differences between the two groups. However, there was a significant difference in the frequency of the L/L genotype between patients (37.25%) and controls (9.8%), which permitted differentiation between the two groups.
Conclusion: The L/L genotype was more frequent among fibromyalgia patients. Though considering a polygenic situation and environmental factors, the molecular study of the rs4680 SNP of the COMT gene may be helpful to the identification of susceptible individuals.
Similar articles
- Serotonin-2A receptor and catechol-O-methyltransferase polymorphisms in panic disorder.
Karacetin G, Bayoglu B, Cengiz M, Demir T, Kocabasoglu N, Uysal O, Bayar R, Balcioglu I. Karacetin G, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):5-10. doi: 10.1016/j.pnpbp.2011.10.010. Epub 2011 Oct 19. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22036916 - Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility.
Tander B, Gunes S, Boke O, Alayli G, Kara N, Bagci H, Canturk F. Tander B, et al. Rheumatol Int. 2008 May;28(7):685-91. doi: 10.1007/s00296-008-0525-8. Epub 2008 Jan 15. Rheumatol Int. 2008. PMID: 18196244 - Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.
Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N. Gürsoy S, et al. Rheumatol Int. 2003 May;23(3):104-7. doi: 10.1007/s00296-002-0260-5. Epub 2002 Oct 22. Rheumatol Int. 2003. PMID: 12739038 - Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.
Buskila D, Sarzi-Puttini P. Buskila D, et al. Arthritis Res Ther. 2006;8(5):218. doi: 10.1186/ar2005. Arthritis Res Ther. 2006. PMID: 16887010 Free PMC article. Review. - Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.
Lee YH, Choi SJ, Ji JD, Song GG. Lee YH, et al. Rheumatol Int. 2012 Feb;32(2):417-26. doi: 10.1007/s00296-010-1678-9. Epub 2010 Dec 1. Rheumatol Int. 2012. PMID: 21120487 Review.
Cited by
- The Role of Genetic Polymorphisms in Chronic Pain Patients.
Knezevic NN, Tverdohleb T, Knezevic I, Candido KD. Knezevic NN, et al. Int J Mol Sci. 2018 Jun 8;19(6):1707. doi: 10.3390/ijms19061707. Int J Mol Sci. 2018. PMID: 29890676 Free PMC article. Review. - The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.
Podvin S, Yaksh T, Hook V. Podvin S, et al. Annu Rev Pharmacol Toxicol. 2016;56:511-33. doi: 10.1146/annurev-pharmtox-010715-103042. Annu Rev Pharmacol Toxicol. 2016. PMID: 26738478 Free PMC article. Review. - Cognitive impairment in fibromyalgia.
Bertolucci PH, de Oliveira FF. Bertolucci PH, et al. Curr Pain Headache Rep. 2013 Jul;17(7):344. doi: 10.1007/s11916-013-0344-9. Curr Pain Headache Rep. 2013. PMID: 23709236 Review. - A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.
Ovrom EA, Mostert KA, Khakhkhar S, McKee DP, Yang P, Her YF. Ovrom EA, et al. Biomedicines. 2023 Apr 7;11(4):1119. doi: 10.3390/biomedicines11041119. Biomedicines. 2023. PMID: 37189737 Free PMC article. Review. - Polymorphisms of brain-derived neurotrophic factor genes are associated with anxiety and body mass index in fibromyalgia syndrome patients.
Nugraha B, Anwar SL, Gutenbrunner C, Korallus C. Nugraha B, et al. BMC Res Notes. 2020 Aug 28;13(1):402. doi: 10.1186/s13104-020-05226-8. BMC Res Notes. 2020. PMID: 32859253 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous